IRF7 orchestrates maladaptive smooth muscle cell phenotype switching in atherosclerosis
Precision Clinical Medicine · 30.01.2026 · 9 (1)
DOI: 10.1093/pcmedi/pbaf039 ↗Kurz gefasst
Fachartikel in der Zeitschrift Precision Clinical Medicine, online erschienen am 27.12.2025. Verfasst von Rundong Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Changzheng Hospital, Naval Medical University (Second Military Medical University), Shanghai 611230, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Columbia University.
Abstract (Originalsprache)
Background
Smooth muscle cells (SMCs) exhibit remarkable plasticity, undergoing extensive phenotypic switching to generate a highly heterogeneous population within atherosclerotic plaques. While recent studies have highlighted the contribution of SMC-derived macrophage-like cells to plaque inflammation, the specific molecular drivers governing the transition to these pathogenic states remain poorly understood.
Methods
Here, we re-analyzed single-cell RNA sequencing data from lineage-traced mice to dissect SMC heterogeneity during atherogenesis. Trajectory analysis revealed that SMCs transdifferentiate into a distinct pro-inflammatory macrophage-like subpopulation (macrophage 4) via an intermediate “stem–endothelial–monocyte" cell state. Integrated gene regulatory network inference and in silico perturbation modeling identified interferon regulatory factor 7 (IRF7) as a master transcriptional regulator orchestrating this specific pathogenic transition.
Results
Clinically, IRF7 expression was significantly upregulated in unstable and advanced human atherosclerotic plaques, correlating strongly with inflammatory macrophage burden. In vivo, ApoE−/− mice challenged with a high-fat diet exhibited robust upregulation of IRF7 in aortic plaques, which co-localized with macrophage markers. Crucially, SMC-specific knockdown of Irf7 using an AAV-SM22α-shIRF7 vector significantly attenuated atherosclerotic plaque progression, reduced necrotic core formation, and enhanced fibrous cap stability. Mechanistically, Irf7 silencing preserved the contractile SMC phenotype and inhibited the accumulation of pro-inflammatory SMC-derived macrophage-like cells within the lesion.
Conclusions
These findings identify IRF7 as a critical checkpoint in maladaptive SMC phenotype switching. We demonstrate that IRF7 drives the transdifferentiation of SMCs into a pro-inflammatory macrophage-like state, thereby fueling plaque instability. Consequently, therapeutic strategies capable of inhibiting IRF7-mediated SMC plasticity may prove effective in stabilizing vulnerable atherosclerotic plaques.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Changzheng Hospital, Naval Medical University (Second Military Medical University), Shanghai 611230, China.
- Department of Cell Biology, College of Basic Medical Science, Naval Medical University (Second Military Medical University), Shanghai 571623, China.
- Viterbi School of Enginnering, University of Southern California, Los Angeles, CA 91010, USA.
- Precision Regenerative Medicine Research Centre, Medical Science Division, Macau University of Science and Technology, Macao 999078, China.
- Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, and Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles, Southern Medical University, Guangzhou 510515, China.
Förderung
- National Natural Science Foundation of China
- Columbia University
Zitieren
APA
Cai, R., Chen, X., Zhang, H., Wang, Q., Xie, W., Pan, X., Liang, C., & Zhu, H. (2026). IRF7 orchestrates maladaptive smooth muscle cell phenotype switching in atherosclerosis. Precision Clinical Medicine, 9(1). https://doi.org/10.1093/pcmedi/pbaf039
Vancouver
Cai R, Chen X, Zhang H, Wang Q, Xie W, Pan X, et al. IRF7 orchestrates maladaptive smooth muscle cell phenotype switching in atherosclerosis. Precision Clinical Medicine. 2026;9(1). doi:10.1093/pcmedi/pbaf039
BibTeX
@article{Cai2026,
author = {Cai, Rundong and Chen, Xin and Zhang, Hongxia and Wang, Qi and Xie, Wanrong and Pan, Xinghua and Liang, Chun and Zhu, Haiying},
title = {IRF7 orchestrates maladaptive smooth muscle cell phenotype switching in atherosclerosis},
journal = {Precision Clinical Medicine},
year = {2026},
volume = {9},
number = {1},
doi = {10.1093/pcmedi/pbaf039}
}
EUVIMED